Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents. 2014

Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
Key Laboratory of Industrial Microbiology, Ministry of Education, College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, PR China; Tianjin Key Laboratory of Industry Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, PR China.

Forty four di- or trisubstituted novel isatin derivatives were designed and synthesized in 5-6 steps in 25-45% overall yields. Their structures were confirmed by (1)H NMR and (13)C NMR as well as LC-MS. The anticancer activity of these new isatin derivatives against three human tumor cell lines, K562, HepG2 and HT-29, were evaluated by MTT assay in vitro. SAR studies suggested that the combination of 1-benzyl and 5-[trans-2-(methoxycarbonyl)ethen-1-yl] substitution greatly enhance their cytotoxic activity, whereas an intact carbonyl functionality on C-3 as present in the parent ring is required to such a potency. This study leads to the identification of two highly active molecules, compounds 2h (IC50=3 nM) and 2k (IC50=6 nM), against human leukemia K562 cells.

UI MeSH Term Description Entries
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell
D019073 HT29 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells such as the GOBLET CELLS. HT-29 Cells,Cell, HT-29,Cell, HT29,Cells, HT-29,Cells, HT29,HT 29 Cells,HT-29 Cell,HT29 Cell
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562

Related Publications

Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
January 2013, Iranian journal of pharmaceutical research : IJPR,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
January 2014, Iranian journal of pharmaceutical research : IJPR,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
January 2018, Drug design, development and therapy,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
January 2020, Bioorganic chemistry,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
August 2021, Molecules (Basel, Switzerland),
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
May 2015, European journal of medicinal chemistry,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
January 2021, Bioorganic chemistry,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
April 2023, Bioorganic & medicinal chemistry letters,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
October 2017, Bioorganic & medicinal chemistry letters,
Kailin Han, and Yao Zhou, and Fengxi Liu, and Qiannan Guo, and Pengfei Wang, and Yao Yang, and Binbin Song, and Wei Liu, and Qingwei Yao, and Yuou Teng, and Peng Yu
July 2014, Iranian journal of basic medical sciences,
Copied contents to your clipboard!